Sorcin, a Potential Therapeutic Target for Reversing Multidrug Resistance in Cancer

Overview

Journal J Physiol Biochem

Specialties Biochemistry
Physiology

Date 2012 Jun 16

PMID 22701893

Citations 5

Authors

Bei-Bei Zheng

Peng Zhang

Wei-Wei Jia

Lu-Gang Yu

Xiu-Li Guo

Affiliations

Soon will be listed here.

Citing Articles

Clinical Significance and Prognostic Value of Human Soluble Resistance-Related Calcium-Binding Protein: A Pan-Cancer Analysis.

Zhang J, Chen J, Shan B, Lin L, Dong J, Sun Q Front Med (Lausanne). 2021; 8:752619.

PMID: 34869449 PMC: 8635117. DOI: 10.3389/fmed.2021.752619.

Broad regulation of gene isoform expression by Wnt signaling in cancer.

Idris M, Harmston N, Petretto E, Madan B, Virshup D RNA. 2019; 25(12):1696-1713.

PMID: 31506381 PMC: 6859862. DOI: 10.1261/rna.071506.119.

Binding of doxorubicin to Sorcin impairs cell death and increases drug resistance in cancer cells.

Genovese I, Fiorillo A, Ilari A, Masciarelli S, Fazi F, Colotti G Cell Death Dis. 2017; 8(7):e2950.

PMID: 28726784 PMC: 5550883. DOI: 10.1038/cddis.2017.342.

shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.

Xu P, Jiang Y, Wang J Int J Clin Exp Pathol. 2015; 8(3):2300-10.

PMID: 26045737 PMC: 4440046.

Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1.

Maddalena F, Sisinni L, Lettini G, Condelli V, Matassa D, Piscazzi A Mol Oncol. 2013; 7(5):895-906.

PMID: 23735188 PMC: 5528458. DOI: 10.1016/j.molonc.2013.04.009.

References

Chuthapisith S, Bean B, Cowley G, Eremin J, Samphao S, Layfield R . Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy. Eur J Cancer. 2009; 45(7):1274-1281. DOI: 10.1016/j.ejca.2008.12.026. View

Zamparelli C, Ilari A, Verzili D, VECCHINI P, CHIANCONE E . Calcium- and pH-linked oligomerization of sorcin causing translocation from cytosol to membranes. FEBS Lett. 1997; 409(1):1-6. DOI: 10.1016/s0014-5793(97)00464-x. View

Fowler M, Colotti G, Chiancone E, Smith G, Fearon I . Sorcin modulates cardiac L-type Ca2+ current by functional interaction with the alpha1C subunit in rabbits. Exp Physiol. 2008; 93(12):1233-8. DOI: 10.1113/expphysiol.2008.043497. View

Xie X, Dwyer M, Swenson L, Parker M, Botfield M . Crystal structure of calcium-free human sorcin: a member of the penta-EF-hand protein family. Protein Sci. 2001; 10(12):2419-25. PMC: 2374028. DOI: 10.1110/ps.36701. View

Brownawell A, Creutz C . Calcium-dependent binding of sorcin to the N-terminal domain of synexin (annexin VII). J Biol Chem. 1997; 272(35):22182-90. DOI: 10.1074/jbc.272.35.22182. View

Li J, Chen B, Zhu M, Gao F, Ding J, Gao C . [Influence of tetrandrine on SORCIN gene expression in K562/A02 cell line]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008; 16(1):65-9. View

Kobayashi T, Yamada Y, Fukao M, Tsutsuura M, Tohse N . Regulation of Cav1.2 current: interaction with intracellular molecules. J Pharmacol Sci. 2007; 103(4):347-53. DOI: 10.1254/jphs.cr0070012. View

Jin J, Hulette C, Wang Y, Zhang T, Pan C, Wadhwa R . Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease. Mol Cell Proteomics. 2006; 5(7):1193-204. DOI: 10.1074/mcp.M500382-MCP200. View

Rueda A, Song M, Toro L, Stefani E, Valdivia H . Sorcin modulation of Ca2+ sparks in rat vascular smooth muscle cells. J Physiol. 2006; 576(Pt 3):887-901. PMC: 1890400. DOI: 10.1113/jphysiol.2006.113951. View

10.

Verzili D, Zamparelli C, Mattei B, Noegel A, CHIANCONE E . The sorcin-annexin VII calcium-dependent interaction requires the sorcin N-terminal domain. FEBS Lett. 2000; 471(2-3):197-200. DOI: 10.1016/s0014-5793(00)01396-x. View

11.

Yang Y, Xiao Z, Chen Z, Zhang G, Yi H, Zhang P . Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR. Proteomics. 2006; 6(6):2009-21. DOI: 10.1002/pmic.200402031. View

12.

Parekh H, Deng H, Choudhary K, Houser S, Simpkins H . Overexpression of sorcin, a calcium-binding protein, induces a low level of paclitaxel resistance in human ovarian and breast cancer cells. Biochem Pharmacol. 2002; 63(6):1149-58. DOI: 10.1016/s0006-2952(02)00850-x. View

13.

Witkowski J, Miller R . Calcium signal abnormalities in murine T lymphocytes that express the multidrug transporter P-glycoprotein. Mech Ageing Dev. 1999; 107(2):165-80. DOI: 10.1016/s0047-6374(98)00147-x. View

14.

Fowler M, Colotti G, Chiancone E, Higuchi Y, Seidler T, Smith G . Complex modulation of L-type Ca(2+) current inactivation by sorcin in isolated rabbit cardiomyocytes. Pflugers Arch. 2008; 457(5):1049-60. DOI: 10.1007/s00424-008-0575-5. View

15.

Wilkinson D, Turner E, Parkin E, Garner A, Harrison P, Crawford M . Membrane raft actin deficiency and altered Ca2+-induced vesiculation in stomatin-deficient overhydrated hereditary stomatocytosis. Biochim Biophys Acta. 2007; 1778(1):125-32. DOI: 10.1016/j.bbamem.2007.09.016. View

16.

Twentyman P, Reeve J, Koch G, Wright K . Chemosensitisation by verapamil and cyclosporin A in mouse tumour cells expressing different levels of P-glycoprotein and CP22 (sorcin). Br J Cancer. 1990; 62(1):89-95. PMC: 1971747. DOI: 10.1038/bjc.1990.235. View

17.

Szakacs G, Paterson J, Ludwig J, Booth-Genthe C, Gottesman M . Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 2006; 5(3):219-34. DOI: 10.1038/nrd1984. View

18.

Yang Y, Chen Z, Zhang G, Yi H, Xiao Z . A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line. J Cell Biochem. 2008; 104(3):1010-21. DOI: 10.1002/jcb.21687. View

19.

MEYERS M, Biedler J . Increased synthesis of a low molecular weight protein in vincristine-resistant cells. Biochem Biophys Res Commun. 1981; 99(1):228-35. DOI: 10.1016/0006-291x(81)91736-8. View

20.

Zhou Y, Xu Y, Tan Y, Qi J, Xiao Y, Yang C . Sorcin, an important gene associated with multidrug-resistance in human leukemia cells. Leuk Res. 2005; 30(4):469-76. DOI: 10.1016/j.leukres.2005.08.024. View